EcoR1 Capital »

Zenas Biopharma shares owned by EcoR1 Capital

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $29M 790k 36.31

More positions owned by EcoR1 Capital

Zymeworks Del (ZYME)
Anaptysbio Inc Common (ANAB)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Crinetics Pharmaceuticals In (CRNX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crispr Therapeutics Namen Akt (CRSP)
Mbx Biosciences (MBX)
Immunome (IMNM)
Oric Pharmaceuticals (ORIC)
Galapagos Nv Spon Adr (GLPG)
Xencor (XNCR)
Cg Oncology (CGON)
Bridgebio Oncology Therapeut Com New (BBOT)
Eton Pharmaceuticals (ETON)
Zenas Biopharma (ZBIO)

View all positions for EcoR1 Capital

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Federated Investors
Fairmount Funds Management
NVP Associates
Vanguard Group
Novo A/S
BlackRock
Polar Capital Holdings
Wellington Management Company
Vivo Capital
Arrowpoint Asset Management
EcoR1 Capital

View all funds holding Zenas Biopharma